Intelligent Bio Solutions Inc. (INBS) Non Operating Investment Income (2020 - 2023)

Intelligent Bio Solutions' Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $44488.0 for Q4 2023.

• In Q4 2023, Non Operating Investment Income fell 97.52% year-over-year to $44488.0; the TTM figure through Mar 2024 stood at $267225.0 (down 87.05% YoY), while the FY2023 annual figure was $2.2 million, changed N/A from the prior year.
• Non Operating Investment Income for Q4 2023 stood at $44488.0, down from $131250.0 in the prior quarter.
• The five-year high for Non Operating Investment Income was $1.8 million in Q4 2022, with the low at -$135692.0 in Q3 2020.
• The 3-year median for Non Operating Investment Income is $111368.5 (2023), against an average of $365735.2.
• Peak annual rise in Non Operating Investment Income reached 97.52% in 2023, while the deepest fall reached 97.52% in 2023.
• Intelligent Bio Solutions' Non Operating Investment Income stood at -$135692.0 in 2020, then surged by 1421.44% to $1.8 million in 2022, then plunged by 97.52% to $44488.0 in 2023.
• Business Quant data shows INBS's Non Operating Investment Income at $44488.0 in Q4 2023, $131250.0 in Q3 2023, and $91487.0 in Q2 2023.